Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients - A closer inspection will improve your vision".
Baron D, Pasquier D, Pace-Loscos T, Vandendorpe B, Schiappa R, Ortholan C, Hannoun-Levi JM. Baron D, et al. Among authors: pace loscos t. Clin Transl Radiat Oncol. 2024 Feb 21;46:100755. doi: 10.1016/j.ctro.2024.100755. eCollection 2024 May. Clin Transl Radiat Oncol. 2024. PMID: 38440793 Free PMC article. No abstract available.
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis.
Baron D, Pasquier D, Pace-Loscos T, Vandendorpe B, Schiappa R, Ortholan C, Hannoun-Levi JM. Baron D, et al. Among authors: pace loscos t. Clin Transl Radiat Oncol. 2023 Dec 8;45:100710. doi: 10.1016/j.ctro.2023.100710. eCollection 2024 Mar. Clin Transl Radiat Oncol. 2023. PMID: 38179575 Free PMC article.
The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Sun Myint A, Rao C, Barbet N, Thamphya B, Pace-Loscos T, Schiappa R, Magné N, Martel-Lafay I, Mineur L, Deberne M, Zilli T, Dhadda A, Gerard JP. Sun Myint A, et al. Among authors: pace loscos t. Colorectal Dis. 2023 Nov;25(11):2160-2169. doi: 10.1111/codi.16773. Epub 2023 Oct 13. Colorectal Dis. 2023. PMID: 37837240 Clinical Trial.
Single-Masked Randomized Phase 2 Study Assessing 2 Forms of Hypofractionated Proton Therapy in Patients With Large Choroidal Melanomas.
Thariat J, Mathis T, Pace-Loscos T, Peyrichon ML, Maschi C, Rosier L, Nguyen M, Bonnin N, Aloi D, Gastaud L, Gaucher D, Caujolle JP, Château Y, Herault J. Thariat J, et al. Among authors: pace loscos t. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):357-369. doi: 10.1016/j.ijrobp.2023.04.028. Epub 2023 May 29. Int J Radiat Oncol Biol Phys. 2023. PMID: 37257661 Clinical Trial.
Enteral Nutrition during Radiotherapy for Oropharyngeal Cancers: Prevalence and Prognostic Factors Based on HPV Status (A GETTEC Study).
Culié D, Schiappa R, Pace-Loscos T, Guelfucci B, Vergez S, Garrel R, Fakhry N, Dassonville O, Poissonnet G, Lallemant B, Sudaka A, Saada-Bouzid E, Benezery K, Temam S, Gorphe P, Chamorey E, Bozec A. Culié D, et al. Among authors: pace loscos t. J Clin Med. 2023 Apr 28;12(9):3169. doi: 10.3390/jcm12093169. J Clin Med. 2023. PMID: 37176609 Free PMC article.
Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer.
Ferrero JM, Mahammedi H, Gravis G, Roubaud G, Beuzeboc P, Largillier R, Borchiellini D, Linassier C, Ebran N, Pace-Loscos T, Etienne-Grimaldi MC, Schiappa R, Gal J, Milano G. Ferrero JM, et al. Among authors: pace loscos t. Pharmaceutics. 2023 Feb 15;15(2):651. doi: 10.3390/pharmaceutics15020651. Pharmaceutics. 2023. PMID: 36839973 Free PMC article.